GlaxoSmithKline Pharmaceuticals Balance Sheet Health
Financial Health criteria checks 6/6
GlaxoSmithKline Pharmaceuticals has a total shareholder equity of ₹16.7B and total debt of ₹0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are ₹37.5B and ₹20.7B respectively. GlaxoSmithKline Pharmaceuticals's EBIT is ₹9.6B making its interest coverage ratio -13.5. It has cash and short-term investments of ₹21.1B.
Key information
0%
Debt to equity ratio
₹0
Debt
| Interest coverage ratio | -13.5x |
| Cash | ₹21.11b |
| Equity | ₹16.73b |
| Total liabilities | ₹20.73b |
| Total assets | ₹37.46b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 500660's short term assets (₹30.1B) exceed its short term liabilities (₹18.1B).
Long Term Liabilities: 500660's short term assets (₹30.1B) exceed its long term liabilities (₹2.6B).
Debt to Equity History and Analysis
Debt Level: 500660 is debt free.
Reducing Debt: 500660 has no debt compared to 5 years ago when its debt to equity ratio was 0.01%.
Debt Coverage: 500660 has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: 500660 has no debt, therefore coverage of interest payments is not a concern.